II
ImmunityBio, Inc. - Common Stock
IBRX
Close · 10/09/2026
7.72
1D
-4.22%52-week range
1.95 – 12.43
Volume
87,97,200.00
Price history
IBRX
11/08/2026 to 10/09/2026
O 7.87 H 7.89 L 7.64
1W-2.89%
1M+1.58%
3M+10.60%
6M-6.65%
1Y+200.39%
3Y+428.77%
5Y-34.58%
MAX-38.88%
Fundamentals
as of 10/09/2026- Market cap
- $8.18B
- Shares out
- 1.06B
- P/E (forward)
- -63.79
- EPS (trailing)
- -0.94
- Beta
- 0.14
- Profit margin
- -598.56%
- P/B
- -8.13
SEC financial statements
45 quarterly and 13 annual periods through 30/06/2026.
Details
- Ticker
- IBRX
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 0 buys · 1 sell · ?: 1
- 06/03/2023Daniel GoldmanSellImmunityBio, Inc.$1,001–$15,000